
45. Psycholytic therapy with MDMA and LSD with Dr Peter Gasser
About this episode
Today’s episode features Dr Peter Gasser, the president of the Swiss Medical Society for Psycholytic Therapy.
Professor Nutt and Dr Gasser talk about the rather unusual and innovative attitude to psychedelic research in Switzerland.
How can Britain learn from the Swiss? What are the drug policies in the Albert Hofmann’s - the discoverer of LSD - country?
Dr Peter Gasser is a Swiss psychiatrist and psychotherapist and the President of the Swiss Medical Society for Psycholytic Therapy since 1997. After LSD was criminalized worldwide he was the first person to conduct research on psychedelic-assisted psychotherapy. Additionally, he holds a permission for and provides treatment using MDMA and LSD.
Swiss Medical Society for Psycholytic Therapy
International Symposium on the Occasion of the 100th Birthday of Albert Hofmann
Post-traumatic stress disorder
MAPS - Multidisciplinary Association for Psychedelic Studies
War on drugs - US political campaign
Pilot study on LSD-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Psycholytic therapy with MDMA and LSD in Switzerland - MAPS article
★ Support this podcast ★Get every episode summarized
Each time The Drug Science Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Drug Science Podcast

158. The Story of Pharmacology with Prof Rod Flower
The Drug Science Podcast

157. Psychedelics and Christianity with Wendi Rees
The Drug Science Podcast

156. Training Grandmothers to Treat Depression with Dr Dixon Chibanda
The Drug Science Podcast

155. The History of Schizophrenia with Justin Garson
The Drug Science Podcast